Abiopharma

BETTERLIFE PHARMA INC. (BETRF)

Symbol	BETRF
Name	BETTERLIFE PHARMA INC.
Sector	UNDEFINED
Region	North America
Industry	-
Address	V6H 1A6 Canada BC 1275 WEST 6TH AVENUE #300
Telephone	604-805-7783
Fax	—
Email	—
Website	https://abetterlifepharma.com/
Incorporation	CA
Incorporated On	2002
Employees	—
Fiscal Year	1/31
Public Since	—
Exchanges	OTC;NASDAQ
Auditor	MNP LLP;
Audit Status	AUDITED
Reporting Status	U.S. Reporting: SEC Reporting
CIK	0001464165
Description	BetterLife Pharma Inc. is an emerging biotechnology company primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. Additional info from OTC: BetterLife Pharma Inc. is an emerging biotechnology company primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders.

2026-04-08 13:00

BetterLife Announces Private Placement Offering of Units

2026-04-02 13:00

BetterLife Pharma Announces Debt Conversions

2026-02-23 14:00

BetterLife Announces Stock Option Grant

2026-01-06 14:00

BetterLife Pharma to Participate in YAFO Capital Access Asia Partnering Forum During JPM Week in San Francisco

2025-12-04 21:54

BetterLife Pharma Highlights Advantages of BETR-001 – a Potent Neuroplastogen

2025-11-25 20:23

BetterLife Pharma Welcomes Daniel Carcillo as Corporate Advisor

2025-10-21 20:26

BetterLife Pharma Appoints Doug Drysdale as Corporate Advisor

2025-09-29 21:04

(10% Negative) BETTERLIFE PHARMA INC. (BETRF) Announces Clinical Development Update (Form 6-K)

2025-07-28 21:00

(99% Neutral) BETTERLIFE PHARMA INC. (BETRF) Announces 2025 Annual General Meeting

2025-06-27 17:31

(10% Negative) BETTERLIFE PHARMA INC. (BETRF) Announces Clinical Development Update (Form 6-K)